1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabis-based Medicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 CBD (Cannabidiol) Based
1.2.3 THC (Tetrahydrocannabinol) Based
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cannabis-based Medicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oral Solution
1.3.3 Tablets
1.3.4 Patches
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Cannabis-based Medicines Market Perspective (2017-2028)
2.2 Cannabis-based Medicines Growth Trends by Region
2.2.1 Cannabis-based Medicines Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cannabis-based Medicines Historic Market Size by Region (2017-2022)
2.2.3 Cannabis-based Medicines Forecasted Market Size by Region (2023-2028)
2.3 Cannabis-based Medicines Market Dynamics
2.3.1 Cannabis-based Medicines Industry Trends
2.3.2 Cannabis-based Medicines Market Drivers
2.3.3 Cannabis-based Medicines Market Challenges
2.3.4 Cannabis-based Medicines Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Cannabis-based Medicines Players by Revenue
3.1.1 Global Top Cannabis-based Medicines Players by Revenue (2017-2022)
3.1.2 Global Cannabis-based Medicines Revenue Market Share by Players (2017-2022)
3.2 Global Cannabis-based Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cannabis-based Medicines Revenue
3.4 Global Cannabis-based Medicines Market Concentration Ratio
3.4.1 Global Cannabis-based Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabis-based Medicines Revenue in 2021
3.5 Cannabis-based Medicines Key Players Head office and Area Served
3.6 Key Players Cannabis-based Medicines Product Solution and Service
3.7 Date of Enter into Cannabis-based Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Cannabis-based Medicines Breakdown Data by Type
4.1 Global Cannabis-based Medicines Historic Market Size by Type (2017-2022)
4.2 Global Cannabis-based Medicines Forecasted Market Size by Type (2023-2028) 5 Cannabis-based Medicines Breakdown Data by Application
5.1 Global Cannabis-based Medicines Historic Market Size by Application (2017-2022)
5.2 Global Cannabis-based Medicines Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Cannabis-based Medicines Market Size (2017-2028)
6.2 North America Cannabis-based Medicines Market Size by Type
6.2.1 North America Cannabis-based Medicines Market Size by Type (2017-2022)
6.2.2 North America Cannabis-based Medicines Market Size by Type (2023-2028)
6.2.3 North America Cannabis-based Medicines Market Share by Type (2017-2028)
6.3 North America Cannabis-based Medicines Market Size by Application
6.3.1 North America Cannabis-based Medicines Market Size by Application (2017-2022)
6.3.2 North America Cannabis-based Medicines Market Size by Application (2023-2028)
6.3.3 North America Cannabis-based Medicines Market Share by Application (2017-2028)
6.4 North America Cannabis-based Medicines Market Size by Country
6.4.1 North America Cannabis-based Medicines Market Size by Country (2017-2022)
6.4.2 North America Cannabis-based Medicines Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Cannabis-based Medicines Market Size (2017-2028)
7.2 Europe Cannabis-based Medicines Market Size by Type
7.2.1 Europe Cannabis-based Medicines Market Size by Type (2017-2022)
7.2.2 Europe Cannabis-based Medicines Market Size by Type (2023-2028)
7.2.3 Europe Cannabis-based Medicines Market Share by Type (2017-2028)
7.3 Europe Cannabis-based Medicines Market Size by Application
7.3.1 Europe Cannabis-based Medicines Market Size by Application (2017-2022)
7.3.2 Europe Cannabis-based Medicines Market Size by Application (2023-2028)
7.3.3 Europe Cannabis-based Medicines Market Share by Application (2017-2028)
7.4 Europe Cannabis-based Medicines Market Size by Country
7.4.1 Europe Cannabis-based Medicines Market Size by Country (2017-2022)
7.4.2 Europe Cannabis-based Medicines Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Cannabis-based Medicines Market Size (2017-2028)
8.2 Asia-Pacific Cannabis-based Medicines Market Size by Type
8.2.1 Asia-Pacific Cannabis-based Medicines Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cannabis-based Medicines Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cannabis-based Medicines Market Share by Type (2017-2028)
8.3 Asia-Pacific Cannabis-based Medicines Market Size by Application
8.3.1 Asia-Pacific Cannabis-based Medicines Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cannabis-based Medicines Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cannabis-based Medicines Market Share by Application (2017-2028)
8.4 Asia-Pacific Cannabis-based Medicines Market Size by Region
8.4.1 Asia-Pacific Cannabis-based Medicines Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cannabis-based Medicines Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Cannabis-based Medicines Market Size (2017-2028)
9.2 Latin America Cannabis-based Medicines Market Size by Type
9.2.1 Latin America Cannabis-based Medicines Market Size by Type (2017-2022)
9.2.2 Latin America Cannabis-based Medicines Market Size by Type (2023-2028)
9.2.3 Latin America Cannabis-based Medicines Market Share by Type (2017-2028)
9.3 Latin America Cannabis-based Medicines Market Size by Application
9.3.1 Latin America Cannabis-based Medicines Market Size by Application (2017-2022)
9.3.2 Latin America Cannabis-based Medicines Market Size by Application (2023-2028)
9.3.3 Latin America Cannabis-based Medicines Market Share by Application (2017-2028)
9.4 Latin America Cannabis-based Medicines Market Size by Country
9.4.1 Latin America Cannabis-based Medicines Market Size by Country (2017-2022)
9.4.2 Latin America Cannabis-based Medicines Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Cannabis-based Medicines Market Size (2017-2028)
10.2 Middle East & Africa Cannabis-based Medicines Market Size by Type
10.2.1 Middle East & Africa Cannabis-based Medicines Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cannabis-based Medicines Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cannabis-based Medicines Market Share by Type (2017-2028)
10.3 Middle East & Africa Cannabis-based Medicines Market Size by Application
10.3.1 Middle East & Africa Cannabis-based Medicines Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cannabis-based Medicines Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cannabis-based Medicines Market Share by Application (2017-2028)
10.4 Middle East & Africa Cannabis-based Medicines Market Size by Country
10.4.1 Middle East & Africa Cannabis-based Medicines Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cannabis-based Medicines Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 GW Pharmaceuticals plc
11.1.1 GW Pharmaceuticals plc Company Details
11.1.2 GW Pharmaceuticals plc Business Overview
11.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Introduction
11.1.4 GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2017-2022)
11.1.5 GW Pharmaceuticals plc Recent Developments
11.2 INSYS Therapeutics
11.2.1 INSYS Therapeutics Company Details
11.2.2 INSYS Therapeutics Business Overview
11.2.3 INSYS Therapeutics Cannabis-based Medicines Introduction
11.2.4 INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2017-2022)
11.2.5 INSYS Therapeutics Recent Developments
11.3 Aequus Pharmaceuticals
11.3.1 Aequus Pharmaceuticals Company Details
11.3.2 Aequus Pharmaceuticals Business Overview
11.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Introduction
11.3.4 Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2017-2022)
11.3.5 Aequus Pharmaceuticals Recent Developments
11.4 Axim Biotechnologies
11.4.1 Axim Biotechnologies Company Details
11.4.2 Axim Biotechnologies Business Overview
11.4.3 Axim Biotechnologies Cannabis-based Medicines Introduction
11.4.4 Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2017-2022)
11.4.5 Axim Biotechnologies Recent Developments
11.5 Revive Therapeutics
11.5.1 Revive Therapeutics Company Details
11.5.2 Revive Therapeutics Business Overview
11.5.3 Revive Therapeutics Cannabis-based Medicines Introduction
11.5.4 Revive Therapeutics Revenue in Cannabis-based Medicines Business (2017-2022)
11.5.5 Revive Therapeutics Recent Developments
11.6 MGC Pharmaceuticals
11.6.1 MGC Pharmaceuticals Company Details
11.6.2 MGC Pharmaceuticals Business Overview
11.6.3 MGC Pharmaceuticals Cannabis-based Medicines Introduction
11.6.4 MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2017-2022)
11.6.5 MGC Pharmaceuticals Recent Developments
11.7 ECHO Pharmaceuticals
11.7.1 ECHO Pharmaceuticals Company Details
11.7.2 ECHO Pharmaceuticals Business Overview
11.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Introduction
11.7.4 ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2017-2022)
11.7.5 ECHO Pharmaceuticals Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
